BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2099083)

  • 1. Plasmid analysis of clinical isolates of Bacteroides fragilis group strains.
    Nagy E; Dányi E; Földes J
    Acta Microbiol Hung; 1990; 37(4):367-73. PubMed ID: 2099083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of beta-lactamases in the Bacteroides fragilis group].
    Martin C; Dubreuil L; Sedallian A; Romond C
    Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
    Nakano V; Padilla G; do Valle Marques M; Avila-Campos MJ
    Res Microbiol; 2004 Dec; 155(10):843-6. PubMed ID: 15567279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curing antibiotic resistance in Bacteroides species by aminoacridines and ethidium bromide.
    Rotimi VO; Duerden BI
    Afr J Med Med Sci; 1982; 10(3-4):91-6. PubMed ID: 6289651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
    Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
    Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of cryptic plasmids in clinical isolates of Bacteroides fragilis.
    Beul HA; von Eichel-Streiber C; Schreiner M; Schwindling FP; Weinblum D; Zöllner EJ; Dierich M
    J Med Microbiol; 1985 Aug; 20(1):39-48. PubMed ID: 2991526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid analyses in clinical isolates of Bacteroides fragilis and other Bacteroides species.
    Wallace BL; Bradley JE; Rogolsky M
    J Clin Microbiol; 1981 Oct; 14(4):383-8. PubMed ID: 6974737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin resistance transfer in Bacteroides fragilis.
    Teng LJ; Liaw SJ; Luh KT; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Nov; 27(4):186-95. PubMed ID: 9747348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-plasmid mediated transfer of beta-lactam resistance in Bacteroides fragilis.
    Yamaoka K; Watanabe K; Muto Y; Katoh N; Ueno K; Tally FP
    J Antibiot (Tokyo); 1990 Oct; 43(10):1302-6. PubMed ID: 2258328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and ecological aspects of antibiotic resistance in the Bacteroides fragilis group.
    Martínez-Suárez JV; Baquero F
    Microbiologia; 1987 Oct; 3(3):149-62. PubMed ID: 3077327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.
    Peterson ML; Rotschafer JC; Piddock LJ
    J Antimicrob Chemother; 2003 Sep; 52(3):481-4. PubMed ID: 12917248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbial drug resistance and the presence of plasmids in Salmonella strains isolated from different sources].
    Luque A; Moriñigo MA; Rodríguez-Avial C; Picazo JJ; Borrego JJ
    Enferm Infecc Microbiol Clin; 1994 Apr; 12(4):187-92. PubMed ID: 8031884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete sequence of pBFUK1, a carbapenemase-harboring mobilizable plasmid from Bacteroides fragilis, and distribution of pBFUK1-like plasmids among carbapenem-resistant B. fragilis clinical isolates.
    Goto T; Tanaka K; Minh Tran C; Watanabe K
    J Antibiot (Tokyo); 2013 Apr; 66(4):239-42. PubMed ID: 23232931
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The occurrence of antibiotic resistance genes in drug resistant Bacteroides fragilis isolates from Groote Schuur Hospital, South Africa.
    Meggersee R; Abratt V
    Anaerobe; 2015 Apr; 32():1-6. PubMed ID: 25460195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological analysis of Salmonella typhi-murium infections on the basis of laboratory methods. II. Resistance to antibiotics and R-plasmid carrier state in Salmonella typhi-murium isolated in Hungary in the period 1974 to 1981.
    Milch H; László VG; Nikolnikov S
    Acta Microbiol Hung; 1985; 32(1):87-98. PubMed ID: 3898705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.